TY - CHAP A1 - Carsten Wrenger A2 - Henning Ulrich ED1 - Izet M. Kapetanovic Y1 - 2011-12-16 PY - 2011 T1 - Drug Discovery by Aptamers in Protozoan Infectious Diseases N2 - Drug discovery and development process aims to make available medications that are safe and effective in improving the length and quality of life and relieving pain and suffering. However, the process is very complex, time consuming, resource intensive, requiring multi-disciplinary expertise and innovative approaches. There is a growing urgency to identify and develop more effective, efficient, and expedient ways to bring safe and effective products to the market. The drug discovery and development process relies on the utilization of relevant and robust tools, methods, models, and validated biomarkers that are predictive of clinical effects in terms of diagnosis, prevention, therapy, and prognosis. There is a growing emphasis on translational research, a bidirectional bench to the bedside approach, in an effort to improve the process efficiency and the need for further innovations. The authors in the book discuss the current and evolving state of drug discovery and development. BT - Drug Discovery and Development SP - Ch. 16 UR - https://doi.org/10.5772/28913 DO - 10.5772/28913 SN - PB - IntechOpen CY - Rijeka Y2 - 2021-09-26 ER -